(firstQuint)Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma.

 The aim of this study is to evaluate the efficacy of doxycycline in relapsed Cutaneous T-cell Lymphomas (CTCL).

 The primary objective is to determine the overall response rate of doxycycline monotherapy in patients with relapsed CTCL.

.

 Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma@highlight

This study looks at the efficacy of Doxycycline for the treatment of Cutaneous T-cell Lymphomas.

